Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA

The latest announcement is out from Focus Graphite ( ($TSE:FMS) ). Focus Graphite has hired Groupe Synergis of BBA Consultants to run a complementa...

Focus Graphite Advances Lac Knife Access Road With New Environmental Field Program

In a report released yesterday, Anchal Verma from J.P. Morgan maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA. The company’s share...

J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Foremost Lithium Resource & Technology Ltd ( ($TSE:FAT) ) has issued an update. Foremost Clean Energy Ltd. has filed an early warning report after ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FMS	$22.35	-0.27%	1.12M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FMS	$22.35	-0.3%	1.12M
3
4
5
6

FMS

Get Fresenius Medical Care AG & Co. KGaA Data in Excel

Get Fresenius Medical Care AG & Co. KGaA Data in Excel